SCHEDULE 13G
Statement of Beneficial Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001104659-26-054220
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…